Expanded Access to NanoDoce for Patients Not Eligible for Current Clinical Trials

Sponsor: NanOlogy, LLC

Expanded Access

Sponsor score: 40

Inactive

ClinicalTrials ID:NCT04060628

NanOlogy is considering providing access to NanoDoce for patients who cannot join ongoing clinical trials due to not meeting the required criteria.

Patient Parameters

Parameter	Options

Program Overview

NanOlogy is exploring the possibility of offering NanoDoce, a treatment option, to patients who are unable to participate in current clinical trials because they do not meet the necessary requirements. This expanded access program aims to provide an opportunity for those patients to receive the treatment outside of the standard clinical trial setting.

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.